Skip to content
Search

Latest Stories

PDA asks pharmacy employers to remain vigilant as long Covid becomes a major issue

The Pharmacists Defence Association (PDA) has stressed that as ‘long Covid’ is turning into an issue for community pharmacists, reporting likely exposure at workplace will be vital for contractors.

The association has reiterated that it is the legal duty of employers to maintain safe and healthy workplaces and to report likely Covid-19 exposure at work resulting in an infection to the Health and Safety Executive (HSE) to ensure the safety of their teams.


Post-Covid-19 syndrome or long Covid can be a condition where the virus can cause symptoms that last weeks or months even after the patient recovers from the disease.

“More is becoming known about long Covid, but it is already clear that it has the potential to be life changing. An individual will not know at the time of infection if they will subsequently develop long Covid or the future impact it may have on their life,” the PDA pointed out.

“As the country, and world learns from this pandemic to be better prepared for future viruses, accurate information will inform our understanding of this condition. It is of paramount importance that employers report when a likely exposure to Covid-19 in an individual’s workplace resulting in an infection has occurred,” it added.

As the PDA has highlighted throughout the pandemic, reporting such incidents to the Health and Safety Executive (HSE) is an obligation for pharmacy employers and is mandatory.

The HSE guidance states: “If there is reasonable evidence that someone diagnosed with Covid-19 was likely exposed because of their work, you must report this as an exposure to a biological agent using the case of disease report. An example of a work-related exposure to coronavirus would be a healthcare professional who is diagnosed with Covid-19 after treating patients with Covid-19.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less